Topic: Magic Mushrooms

Treasury Secretary Janet Yellen admitted to unknowingly consuming a dish containing mushrooms with hallucinogenic properties during a group dinner in Japan. Yellen stated she was unaware of the mushrooms' effects at the time and claimed she felt no ill effects afterward. The anecdote surfaced amidst broader discussions regarding Yellen's oversight of the US dollar and rising inflation.

A study published in Science Direct suggests that psilocybin, the active compound in magic mushrooms, may help treat depression by altering amygdala responses to fearful faces. The research indicates that psilocybin can provide rapid and enduring improvements in emotional processing. The hosts jokingly suggest a psilocybin spray could help "Dimension B" individuals who are fearful of the President.

NBC News reports on two studies showing that psilocybin, the active ingredient in magic mushrooms, significantly reduced anxiety and depression in 80% of cancer patients. The effects lasted for more than six months after a single dose administered under medical supervision. The FDA has also approved large-scale trials using MDMA (ecstasy) for treating PTSD.

NBC reports on new studies showing that psilocybin, the active ingredient in magic mushrooms, significantly reduces anxiety and depression in cancer patients. The FDA has also approved large-scale trials for MDMA (ecstasy) to treat PTSD. The hosts discuss the potential for pharmaceutical companies to monetize these substances as they move toward legalization.